Bioxytran, Inc (BIXT) income statement
BIXTOTCPharmaceutical PreparationsFiscal year ends December 31
$0.02−0.00 (-3.95%)
Close on Oct 19, 2026Market cap $2.56MP/E –Yield –
Bioxytran, Inc financial ratios
See a number that looks wrong?
Close on Oct 19, 2026Market cap $2.56MP/E –Yield –
See a number that looks wrong?
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Margins | ||||||||||||||||||
| Gross margin | – | – | – | – | – | – | – | – | 45.6% | 60.9% | 47.0% | 39.8% | 52.7% | 61.0% | 75.0% | 75.0% | – | – |
| Operating margin | – | – | – | – | – | – | – | – | -162.5% | -272.3% | -817.9% | -464.7% | -472.6% | -731.8% | -5,803.6% | -2,039.6% | – | – |
| Pre-tax margin | – | – | – | – | – | – | – | – | – | -282.7% | -820.9% | -488.7% | -426.2% | – | – | – | – | – |
| Net profit margin | – | – | – | – | – | – | – | – | -166.6% | -282.7% | -820.9% | -488.7% | -426.2% | -732.9% | -5,809.3% | – | – | – |
| Returns on capital | ||||||||||||||||||
| Return on equity | 95.0% | 95.8% | 139.7% | 76.6% | 158.1% | 181.0% | 362.8% | 261.1% | 217.5% | 279.5% | 978.1% | 1,833.9% | -829.1% | -886.6% | -8,264.8% | – | – | – |
| Return on assets | -532.6% | -1,702.2% | -1,752.8% | -1,009.0% | -1,809.2% | -931.3% | -1,451.7% | -1,623.3% | -1,229.7% | -1,296.4% | -2,483.9% | -724.7% | -517.9% | -711.6% | -2,986.5% | – | – | – |
| Return on tangible assets | -837.4% | -43,046.2% | -3,152.7% | -1,458.4% | -2,291.9% | -966.7% | -1,451.7% | -1,623.3% | -1,229.7% | -1,296.4% | -2,483.9% | -724.7% | -517.9% | -711.6% | -2,986.5% | – | – | – |
| Return on invested capital | – | 100.4% | – | – | – | – | – | – | -1,040.5% | – | – | – | – | – | – | – | – | – |
| Return on capital employed | 84.1% | 90.8% | 118.7% | 75.5% | 165.3% | 92.6% | 318.5% | 189.8% | 212.8% | 276.4% | 1,004.3% | 1,754.3% | -918.5% | -885.2% | -6,589.4% | 1,139.1% | – | – |
| Return on total capital | – | 127.5% | – | – | – | – | – | – | -1,311.0% | – | – | – | – | – | – | – | – | – |
| NOPAT | -$1.46M | -$1.76M | -$3.00M | -$1.92M | -$3.33M | -$1.00M | -$1.29M | -$169.94K | -$245.36K | -$530.31K | -$1.65M | -$1.01M | -$1.56M | -$1.81M | -$3.50M | -$259.94K | – | – |
| Cash flow quality | ||||||||||||||||||
| OCF / Sales | – | – | – | – | – | – | – | – | -9.7% | -17.2% | -1.1% | -5.9% | 2.2% | -20.4% | -522.7% | -469.9% | – | – |
| OCF / Net income | 0.25 | 0.16 | 0.17 | 0.73 | 0.42 | 0.43 | 0.23 | 0.63 | 0.06 | 0.06 | 0.00 | 0.01 | -0.01 | 0.03 | 0.09 | – | – | – |
| Efficiency | ||||||||||||||||||
| Asset turnover | – | – | – | – | – | – | – | – | 7.38 | 4.59 | 3.03 | 1.48 | 1.22 | 0.97 | 0.51 | 0.20 | – | – |
| Fixed asset turnover | – | – | – | – | – | – | – | – | 0.54 | 6.40 | 3.21 | 2.02 | 2.84 | 2.11 | 0.70 | 0.32 | – | – |
| Receivables turnover | – | – | – | – | – | – | – | – | 11.74 | 25.68 | – | – | 9.74 | 22.83 | – | – | – | – |
| Days sales outstanding | – | – | – | – | – | – | – | – | 31.1 | 14.2 | – | – | 37.5 | 16.0 | – | – | – | – |
| Payables turnover | – | – | – | – | – | – | – | – | 4.29 | 1.50 | 0.93 | 1.41 | 6.34 | 6.36 | 0.48 | 0.06 | – | – |
| Days payables outstanding | – | – | – | – | – | – | – | – | 85.1 | 243.0 | 393.6 | 259.1 | 57.6 | 57.4 | 763.1 | 6,298.8 | – | – |
| Inventory turnover | – | – | – | – | – | – | – | – | 18.03 | 15.35 | – | – | 15.21 | 6.54 | 1.16 | 0.54 | – | – |
| Days inventory outstanding | – | – | – | – | – | – | – | – | 20.2 | 23.8 | – | – | 24.0 | 55.8 | 314.9 | 677.4 | – | – |
| Operating cycle | – | – | – | – | – | – | – | – | 51.3 | 38.0 | – | – | 61.5 | 71.8 | – | – | – | – |
| Cash conversion cycle | – | – | – | – | – | – | – | – | -33.7 | -205.0 | – | – | 3.9 | 14.4 | – | – | – | – |
| Liquidity | ||||||||||||||||||
| Current ratio | 0.16 | 0.00 | 0.01 | 0.08 | 0.02 | 0.14 | 0.22 | 0.14 | 0.08 | 0.08 | 0.01 | 0.02 | 0.51 | 4.03 | 0.92 | 0.28 | – | – |
| Quick ratio | 0.16 | 0.00 | 0.01 | 0.08 | 0.02 | 0.14 | 0.22 | 0.14 | -3.63 | 0.06 | 0.01 | 0.02 | 0.43 | 3.87 | 0.44 | 0.21 | – | – |
| Cash ratio | 0.16 | 0.00 | 0.01 | 0.08 | 0.02 | 0.02 | 0.17 | 0.14 | 0.08 | 0.03 | 0.01 | 0.02 | 0.11 | 0.07 | 0.31 | 0.21 | – | – |
| Working capital | -$2.74M | -$1.93M | -$3.22M | -$3.37M | -$3.21M | -$1.95M | -$799.29K | -$225.31K | -$1.31K | -$315.30K | -$247.55K | -$328.57K | -$89.86K | $225.00K | -$4.37K | -$79.17K | – | – |
| Net current asset value | -$2.74M | -$1.93M | -$3.22M | -$3.37M | -$3.21M | -$1.95M | -$799.29K | -$225.31K | -$1.31K | -$315.30K | -$247.55K | -$328.57K | -$89.86K | $225.00K | -$4.37K | -$106.31K | – | – |
| Leverage | ||||||||||||||||||
| Total debt | – | $48.00K | – | – | – | – | – | – | $25.00K | – | – | – | – | – | – | – | – | – |
| Net debt | – | $42.85K | – | – | – | – | – | – | $24.89K | – | – | – | – | – | – | – | – | – |
| Debt / Equity | – | -0.03 | – | – | – | – | – | – | -19.10 | – | – | – | – | – | – | – | – | – |
| Debt ratio | – | 34.6% | – | – | – | – | – | – | 22,727.3% | – | – | – | – | – | – | – | – | – |
| Assets to equity | -0.25 | -0.08 | -0.04 | -0.11 | -0.04 | -0.17 | -0.27 | -0.16 | -0.08 | -0.18 | -0.29 | -0.51 | 3.43 | 1.21 | 1.32 | -1.44 | – | – |
| Total debt / Capitalization | – | -2.8% | – | – | – | – | – | – | 105.5% | – | – | – | – | – | – | – | – | – |
| Cash flow to debt | – | -794.4% | – | – | – | – | – | – | -74.1% | – | – | – | – | – | – | – | – | – |
| Intangibles to total assets | 22.0% | 96.3% | 81.3% | 20.4% | 39.3% | 3.1% | – | – | – | – | – | – | – | – | – | – | – | – |
| Interest coverage | ||||||||||||||||||
| EBIT / Interest expense | -13.72 | -26.39 | -19.67 | – | -2.09 | -1.25 | -38.99 | -57.79 | -39.82 | -86.06 | -268.25 | -164.19 | -155.77 | -645.72 | -686.80 | -39.34 | – | – |
| Per share | ||||||||||||||||||
| Revenue per share | – | – | – | – | – | – | – | – | 0.0022 | 0.0088 | 0.02 | 0.05 | 0.11 | 0.10 | 0.03 | 0.02 | – | – |
| EPS (basic) | -0.02 | -0.02 | -0.03 | -0.02 | -0.04 | -0.03 | -0.02 | 0.00 | -0.01 | -0.03 | -0.21 | -0.30 | -0.47 | -1.00 | -3.00 | -0.50 | – | – |
| EPS (diluted) | -0.02 | -0.02 | -0.03 | -0.02 | -0.04 | -0.03 | -0.02 | 0.00 | -0.01 | -0.03 | -0.21 | -0.30 | -0.47 | -1.00 | -3.00 | -0.50 | – | – |
| Book value per share | -0.02 | -0.02 | -0.02 | -0.03 | -0.03 | -0.02 | -0.0092 | -0.0026 | -0.0000 | -0.01 | -0.02 | -0.04 | 0.02 | 0.11 | 0.07 | -0.08 | – | – |
| Tangible book value per share | -0.03 | -0.02 | -0.02 | -0.03 | -0.03 | -0.02 | -0.0092 | -0.0026 | -0.0000 | -0.01 | -0.02 | -0.04 | 0.02 | 0.11 | 0.07 | -0.08 | – | – |
| Cash per share | 0.0047 | 0.0001 | 0.0002 | 0.0024 | 0.0007 | 0.0004 | 0.0020 | 0.0004 | 0.0000 | 0.0004 | 0.0003 | 0.0011 | 0.0053 | 0.0017 | 0.0072 | 0.03 | – | – |
| Operating cash flow per share | -0.0049 | -0.0044 | -0.0054 | -0.01 | -0.02 | -0.01 | -0.0050 | -0.0022 | -0.0002 | -0.0015 | -0.0002 | -0.0028 | 0.0024 | -0.02 | -0.17 | -0.11 | – | – |
| Valuation at period end | ||||||||||||||||||
| Market cap | $6.75M | $7.39M | $21.65M | $59.05M | $43.95M | $23.32M | $24.23M | $43.40M | $73.32M | $16.27M | $17.07M | $69.80M | $343.13M | $190.48M | $179.36M | – | – | – |
| Enterprise value | $6.73M | $7.36M | $20.91M | $58.13M | $44.66M | $23.32M | $24.19M | $43.40M | $73.30M | $16.25M | $17.06M | $69.78M | $343.12M | $190.47M | $179.30M | – | – | – |
| P/S | – | – | – | – | – | – | – | – | 384x | 66.0x | 66.7x | 253x | 822x | 609x | 2,351x | – | – | – |
| P/B | -2.6x | -4.0x | -7.0x | -17.9x | -13.9x | -12.0x | -30.3x | -193x | -41,900x | -55.9x | -82.3x | -315x | 4,575x | 538x | 1,098x | – | – | – |
| P/TBV | -2.4x | -3.8x | -6.7x | -17.5x | -13.7x | -12.0x | -30.3x | -193x | -41,900x | -55.9x | -82.3x | -315x | 4,575x | 538x | 1,098x | – | – | – |
| P/Gross profit | – | – | – | – | – | – | – | – | 842x | 108x | 142x | 637x | 1,560x | 997x | 3,134x | – | – | – |
| P/OCF | -12.8x | -19.4x | -27.9x | -32.7x | -25.9x | -21.2x | -56.2x | -233x | -3,960x | -384x | -6,353x | -4,277x | 37,003x | -2,991x | -450x | – | – | – |
| EV/Sales | – | – | – | – | – | – | – | – | 384x | 65.9x | 66.7x | 253x | 822x | 609x | 2,350x | – | – | – |
| EV/Gross profit | – | – | – | – | – | – | – | – | 842x | 108x | 142x | 636x | 1,560x | 997x | 3,133x | – | – | – |
| EV/OCF | -12.8x | -19.3x | -27.0x | -32.2x | -26.3x | -21.2x | -56.1x | -233x | -3,958x | -383x | -6,349x | -4,276x | 37,002x | -2,991x | -450x | – | – | – |
| Earnings yield | -31.5% | -32.0% | -20.7% | -4.2% | -9.2% | -10.9% | -7.7% | -0.68% | -0.43% | -4.3% | -12.3% | -1.9% | -0.52% | -1.2% | -2.5% | – | – | – |
| Shareholder yield | ||||||||||||||||||
| Debt paydown yield | – | – | – | – | – | – | – | – | – | – | – | – | 0.00% | – | 0.01% | – | – | – |
| Cost structure | ||||||||||||||||||
| SG&A to revenue | – | – | – | – | – | – | – | – | 208.1% | 333.3% | 864.8% | 504.4% | 525.3% | 792.8% | 5,878.6% | 2,114.6% | – | – |
| Per employee | ||||||||||||||||||
| Total employees | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Revenue per employee | – | – | – | – | – | – | – | – | $47.77K | $61.62K | $63.96K | $137.81K | $208.67K | $156.45K | $38.15K | $8.07K | – | – |
| Gross profit per employee | – | – | – | – | – | – | – | – | $21.77K | $37.55K | $30.03K | $54.82K | $109.97K | $95.49K | $28.61K | $6.05K | – | – |
| Operating profit per employee | -$460.63K | -$555.77K | -$950.05K | -$609.14K | -$1.05M | -$317.18K | -$407.87K | -$53.78K | -$77.65K | -$167.82K | -$523.08K | -$640.35K | -$986.24K | -$1.14M | -$2.21M | -$164.52K | – | – |
| Net income per employee | -$530.77K | -$591.67K | -$1.12M | -$618.28K | -$1.01M | -$635.63K | -$464.62K | -$74.10K | -$79.60K | -$174.19K | -$525.03K | -$673.45K | -$889.27K | -$1.15M | -$2.22M | – | – | – |
| Growth | ||||||||||||||||||
| Revenue 1Y growth | – | – | – | – | – | – | – | – | -22.5% | -3.6% | -7.2% | -34.0% | 33.4% | 310.1% | 372.9% | – | – | – |
| Revenue 3Y CAGR | – | – | – | – | – | – | – | – | -11.5% | -16.1% | -6.5% | 53.4% | 195.8% | – | – | – | – | – |
| Revenue 5Y CAGR | – | – | – | – | – | – | – | – | -9.4% | 26.4% | 73.8% | – | – | – | – | – | – | – |
| Gross profit 1Y growth | – | – | – | – | – | – | – | – | -42.0% | 25.0% | 9.6% | -50.2% | 15.2% | 233.8% | 373.0% | – | – | – |
| Gross profit 3Y CAGR | – | – | – | – | – | – | – | – | -7.4% | -11.9% | -14.3% | 24.2% | 162.9% | – | – | – | – | – |
| Gross profit 5Y CAGR | – | – | – | – | – | – | – | – | -14.5% | 21.3% | 58.3% | – | – | – | – | – | – | – |
| EBIT 1Y growth | 17.1% | 41.5% | -56.0% | 42.2% | -232.2% | 22.2% | -658.4% | 30.7% | 53.7% | 67.9% | -63.4% | 35.1% | 13.9% | 48.3% | -1,245.7% | – | – | – |
| Net income 1Y growth | 10.3% | 47.1% | -80.8% | 38.7% | -58.6% | -36.8% | -527.0% | 6.9% | 54.3% | 66.8% | -55.9% | 24.3% | 22.4% | 48.3% | – | – | – | – |
| Diluted EPS 1Y growth | 0.00% | 33.3% | -50.0% | 50.0% | -33.3% | -50.0% | – | 100.0% | 66.7% | 85.7% | 30.0% | 36.2% | 53.0% | 66.7% | -500.0% | – | – | – |
| Operating cash flow 1Y growth | -38.1% | 50.8% | 57.0% | -6.3% | -54.5% | -155.0% | -131.9% | -903.9% | 56.3% | -1,477.6% | 83.5% | -276.0% | 114.6% | 84.0% | -426.0% | – | – | – |
| Total assets 1Y growth | 374.8% | -0.49% | -62.4% | 211.0% | -63.5% | 48.6% | 503.2% | 33,000.9% | -99.8% | -7.4% | -50.7% | -56.2% | -39.7% | 98.3% | 167.7% | – | – | – |
| Total assets 3Y CAGR | 21.1% | 5.2% | -24.7% | 19.1% | 48.5% | 1,337.0% | 62.0% | -13.3% | -90.1% | -41.5% | -49.3% | -19.4% | 47.4% | – | – | – | – | – |
| Total assets 5Y CAGR | 15.1% | -8.8% | 30.8% | 407.7% | 18.2% | 42.4% | 14.2% | -32.4% | -80.9% | -24.9% | -7.1% | – | – | – | – | – | – | – |
| Total assets 10Y CAGR | 28.0% | 2.0% | -6.0% | -1.4% | -5.8% | 15.0% | – | – | – | – | – | – | – | – | – | – | – | – |
| Total equity 1Y growth | -44.6% | – | – | – | -62.7% | -142.9% | -254.7% | -17,112.7% | 99.5% | -48.9% | 11.8% | -393.5% | -78.7% | 116.9% | 391.5% | – | – | – |
Every figure here is calculated from standardized financial statements — hover a row name for the formula — not reported by the company. Valuation multiples use the closing price at the end of that period, not today's price.